ABBVIE INC. vs. Seres Therapeutics, Inc.
ABBVIE INC. (ABBV) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| ABBV | MCRB | |
|---|---|---|
| Market Cap | $467.37 billion | $53.04 million |
| Revenue (TTM) | $64.39 billion | $1.88 million |
| Net Income (TTM) | $6.32 billion | $-22,463,000 |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | MCRB | |
|---|---|---|
| P/E Ratio | 74.92 | — |
| Price / Book | -79.38 | 1.54 |
| Price / Sales | 7.26 | 28.17 |
ABBV leads on 2 of 2 valuation factors.
Profitability
| ABBV | MCRB | |
|---|---|---|
| Net Margin | 9.81% | -1192.94% |
| Return on Equity | -107.29% | -65.05% |
ABBV and MCRB split the profitability factors evenly.
Dividend
| ABBV | MCRB | |
|---|---|---|
| Dividend Yield | 2.61% | — |
| Payout Ratio | 195.48 | — |
ABBV and MCRB split the dividend factors evenly.
Risk & Sentiment
| ABBV | MCRB | |
|---|---|---|
| Short Interest | 0.85% | 47.82% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, MCRB overview, MCRB financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.